THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM?
Main Author: | |
---|---|
Publication Date: | 2024 |
Other Authors: | , , , , , , |
Format: | preprint |
Language: | por |
Source: | SciELO Preprints |
Download full: | https://preprints.scielo.org/index.php/scielo/preprint/view/8812 |
Summary: | Introduction: Recent progress in the bioengineering of cardiac grafts offers a new therapeutic modality for the regeneration of cardiac tissue after myocardial infarction. CD34 is a marker that expresses all hematopoietic and endothelial precursor cells, and functions as a cell adhesion factor. The antibody corresponding to this marker is used in immunohistochemistry to evaluate the formation of new vessels and the presence of stem cells. Objective: To evaluate the effectiveness of omentopexy in neovascularization and stem cells. Methods: Review collecting information published on selected virtual platforms (SciELO – Scientific Electronic Library Online, Google Scholar, Pubmed and Scopus). The search began with descriptors related to the topic, identified through DeCS/MESH in the following: “myocardial ischemia; myocardial revascularization; omentopexy; immunohistochemistry; CD34; stem cells”. They were read by title and summary, with an AND or OR search followed by the full reading of those most closely related to the topic. A total of 23 articles were included. Results: The greater omentum has a remarkable clinical property in containing sites of tissue damage. It increases its tissue volume in response to foreign and inflammatory particles involving several immunomodulatory cells with progenitor cells, in a process called “omentum activation”. Conclusion: Cardio-omentopexy associated with mechanical abrasion and myocardial perforations proves to be efficient in inducing neovascularization. The greater omentum promotes stem cells - confirmed by CD34 -, demonstrating great potential as a future therapy to restore areas of ischemic myocardium. |
id |
SCI-1_83769e42f753d67af17a1ae464b61b13 |
---|---|
oai_identifier_str |
oai:ops.preprints.scielo.org:preprint/8812 |
network_acronym_str |
SCI-1 |
network_name_str |
SciELO Preprints |
repository_id_str |
|
spelling |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM?O OMENTO MAIOR PODE SER DOADOR DE CÉLULAS-TRONCO AO MIOCÁRDIO ISQUÊMICO? Isquemia miocárdicaRevascularização miocárdicaCD34Células-troncoStem cellMyocardial ischemiaImmunohistochemistryCD34Introduction: Recent progress in the bioengineering of cardiac grafts offers a new therapeutic modality for the regeneration of cardiac tissue after myocardial infarction. CD34 is a marker that expresses all hematopoietic and endothelial precursor cells, and functions as a cell adhesion factor. The antibody corresponding to this marker is used in immunohistochemistry to evaluate the formation of new vessels and the presence of stem cells. Objective: To evaluate the effectiveness of omentopexy in neovascularization and stem cells. Methods: Review collecting information published on selected virtual platforms (SciELO – Scientific Electronic Library Online, Google Scholar, Pubmed and Scopus). The search began with descriptors related to the topic, identified through DeCS/MESH in the following: “myocardial ischemia; myocardial revascularization; omentopexy; immunohistochemistry; CD34; stem cells”. They were read by title and summary, with an AND or OR search followed by the full reading of those most closely related to the topic. A total of 23 articles were included. Results: The greater omentum has a remarkable clinical property in containing sites of tissue damage. It increases its tissue volume in response to foreign and inflammatory particles involving several immunomodulatory cells with progenitor cells, in a process called “omentum activation”. Conclusion: Cardio-omentopexy associated with mechanical abrasion and myocardial perforations proves to be efficient in inducing neovascularization. The greater omentum promotes stem cells - confirmed by CD34 -, demonstrating great potential as a future therapy to restore areas of ischemic myocardium.Introdução: Recentes progressos feitos na bioengenharia de enxertos cardíacos oferecem nova modalidade terapêutica para a regeneração do tecido cardíaco pós-infarto do miocárdio. O CD34 é marcador que expressa todas as células precursoras hematopoiéticas e endoteliais, e funciona como fator de adesão celular. O anticorpo que correspondente a este marcador é utilizado na imunoistoquímica para avaliar a formação de novos vasos e a presença de células-tronco. Objetivo: Avaliar a eficácia da omentopexia na neovascularização e células-tronco. Métodos: Revisão colhendo informações publicadas em plataformas virtuais selecionadas (SciELO – Scientific Electronic Library Online, Google Scholar, Pubmed e Scopus). A busca iniciou-se por descritores relacionados ao tema, identificados por meio do DeCS/MESH nos seguintes descritores: “isquemia miocárdica; revascularização miocárdica; omentopexia; imunoistoquímica; CD34; células-tronco” e seus equivalentes em inglês: “stem cell; myocardial ischemia; myocardial revascularization; omentopexy; immunohistochemistry; CD34”. Foram lidos pelo título e resumo, com busca AND ou OR seguindo-se da leitura na íntegra daqueles com maior relação ao tema. Foram incluídos o total de 23 artigos. Resultados: O omento maior tem propriedade clínica marcante em conter sítios de danos teciduais. Ele aumenta seu volume tecidual em resposta às partículas estranhas e inflamatórias envolvendo diversas células imunomoduladoras com células progenitoras, em um processo chamado “ativação do omento”. Conclusão: A cárdio-omentopexia associada à abrasão mecânica e perfurações miocárdicas, mostra ser eficiente na indução de neovascularização. O omento maior promove células-tronco - confirmadas pelo CD34 -, demonstrando grande potencial como futura terapêutica para restaurar áreas de miocárdio isquêmico.SciELO PreprintsSciELO PreprintsSciELO Preprints2024-04-24info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/881210.1590/SciELOPreprints.8812porhttps://preprints.scielo.org/index.php/scielo/preprint/view/8812/16463Copyright (c) 2024 Fernando Bermudez Kubrusly , Jurandir Marcondes Ribas Filho, Paulo Afonso Nunes Nassif , Douglas Mesadri Gewehr , João Lucchese Piovesan, Oscar Capistrano dos Santos , Geraldo Odilon do Nascimento-Filho , Luiz Fernando Kubrusly https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessKubrusly , Fernando BermudezRibas Filho, Jurandir MarcondesNassif , Paulo Afonso NunesGewehr , Douglas MesadriPiovesan, João LuccheseSantos , Oscar Capistrano dosNascimento-Filho , Geraldo Odilon doKubrusly , Luiz Fernandoreponame:SciELO Preprintsinstname:Scientific Electronic Library Online (SCIELO)instacron:SCI2024-04-24T16:43:08Zoai:ops.preprints.scielo.org:preprint/8812Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2024-04-24T16:43:08SciELO Preprints - Scientific Electronic Library Online (SCIELO)false |
dc.title.none.fl_str_mv |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? O OMENTO MAIOR PODE SER DOADOR DE CÉLULAS-TRONCO AO MIOCÁRDIO ISQUÊMICO? |
title |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
spellingShingle |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? Kubrusly , Fernando Bermudez Isquemia miocárdica Revascularização miocárdica CD34 Células-tronco Stem cell Myocardial ischemia Immunohistochemistry CD34 |
title_short |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
title_full |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
title_fullStr |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
title_full_unstemmed |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
title_sort |
THE GREATER OMENTUM CAN BE A STEM CELL DONOR TO THE ISCHEMIC MYOCARDIUM? |
author |
Kubrusly , Fernando Bermudez |
author_facet |
Kubrusly , Fernando Bermudez Ribas Filho, Jurandir Marcondes Nassif , Paulo Afonso Nunes Gewehr , Douglas Mesadri Piovesan, João Lucchese Santos , Oscar Capistrano dos Nascimento-Filho , Geraldo Odilon do Kubrusly , Luiz Fernando |
author_role |
author |
author2 |
Ribas Filho, Jurandir Marcondes Nassif , Paulo Afonso Nunes Gewehr , Douglas Mesadri Piovesan, João Lucchese Santos , Oscar Capistrano dos Nascimento-Filho , Geraldo Odilon do Kubrusly , Luiz Fernando |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Kubrusly , Fernando Bermudez Ribas Filho, Jurandir Marcondes Nassif , Paulo Afonso Nunes Gewehr , Douglas Mesadri Piovesan, João Lucchese Santos , Oscar Capistrano dos Nascimento-Filho , Geraldo Odilon do Kubrusly , Luiz Fernando |
dc.subject.por.fl_str_mv |
Isquemia miocárdica Revascularização miocárdica CD34 Células-tronco Stem cell Myocardial ischemia Immunohistochemistry CD34 |
topic |
Isquemia miocárdica Revascularização miocárdica CD34 Células-tronco Stem cell Myocardial ischemia Immunohistochemistry CD34 |
description |
Introduction: Recent progress in the bioengineering of cardiac grafts offers a new therapeutic modality for the regeneration of cardiac tissue after myocardial infarction. CD34 is a marker that expresses all hematopoietic and endothelial precursor cells, and functions as a cell adhesion factor. The antibody corresponding to this marker is used in immunohistochemistry to evaluate the formation of new vessels and the presence of stem cells. Objective: To evaluate the effectiveness of omentopexy in neovascularization and stem cells. Methods: Review collecting information published on selected virtual platforms (SciELO – Scientific Electronic Library Online, Google Scholar, Pubmed and Scopus). The search began with descriptors related to the topic, identified through DeCS/MESH in the following: “myocardial ischemia; myocardial revascularization; omentopexy; immunohistochemistry; CD34; stem cells”. They were read by title and summary, with an AND or OR search followed by the full reading of those most closely related to the topic. A total of 23 articles were included. Results: The greater omentum has a remarkable clinical property in containing sites of tissue damage. It increases its tissue volume in response to foreign and inflammatory particles involving several immunomodulatory cells with progenitor cells, in a process called “omentum activation”. Conclusion: Cardio-omentopexy associated with mechanical abrasion and myocardial perforations proves to be efficient in inducing neovascularization. The greater omentum promotes stem cells - confirmed by CD34 -, demonstrating great potential as a future therapy to restore areas of ischemic myocardium. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-04-24 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/preprint info:eu-repo/semantics/publishedVersion |
format |
preprint |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/preprint/view/8812 10.1590/SciELOPreprints.8812 |
url |
https://preprints.scielo.org/index.php/scielo/preprint/view/8812 |
identifier_str_mv |
10.1590/SciELOPreprints.8812 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/preprint/view/8812/16463 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
dc.source.none.fl_str_mv |
reponame:SciELO Preprints instname:Scientific Electronic Library Online (SCIELO) instacron:SCI |
instname_str |
Scientific Electronic Library Online (SCIELO) |
instacron_str |
SCI |
institution |
SCI |
reponame_str |
SciELO Preprints |
collection |
SciELO Preprints |
repository.name.fl_str_mv |
SciELO Preprints - Scientific Electronic Library Online (SCIELO) |
repository.mail.fl_str_mv |
scielo.submission@scielo.org |
_version_ |
1831964356894523392 |